Andrew Pucher is the CEO of Dascena and a member of the Board of Directors. Andrew is a strategic healthcare leader, with extensive experience in developing new product markets and scaling commercial businesses. Prior to joining Dascena, Andrew served as Chief Corporate Director at Goldman Sachs, where he worked for over a decade as a healthcare investment banker financing and advising leading biotech, pharma, and medical device companies. Andrew holds a JD/MBA from York University in Toronto, Canada.
As we near two years since Covid-19 first struck the U.S., our healthcare system continues to grapple with staffing shortages, sicker patients, and an aging population, leading to an overburdened workforce. Luckily, there are technologies – such as machine learning algorithms (MLAs) and artificial intelligence – that continue to evolve and support care teams in […]